4//SEC Filing
GOLD DANIEL P PHD 4
Accession 0001209191-20-043719
CIK 0001262104other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 1:59 PM ET
Size
7.1 KB
Accession
0001209191-20-043719
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
GOLD DANIEL P PHD
DirectorPresident and Chief Executive
Transactions
- Exercise/Conversion
Common Stock
2020-07-23$1.57/sh+12,000$18,840→ 453,632 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-07-23−12,000→ 275,500 totalExercise: $1.57Exp: 2025-07-28→ Common Stock (275,500 underlying)
Footnotes (2)
- [F1]80,000 securities consist of restricted stock units, which shall vest on July 2, 2021, one-year anniversary of the date of grant.
- [F2]All of the options are fully vested and currently exercisable.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeother
Related Parties
1- filerCIK 0001288233
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 1:59 PM ET
- Size
- 7.1 KB